Use your antibodies-online credentials, if available.
Il n’y a pas de produits dans votre liste de comparaison.
Votre panier est vide.
HPGD encodes a member of the short-chain nonmetalloenzyme alcohol dehydrogenase protein family. De plus, nous expédions HPGD Anticorps (128) et HPGD Protéines (16) et beaucoup plus de produits pour cette protéine.
Showing 10 out of 17 products:
15-PGDH prevents lipopolysaccharide-induced acute liver injury in mice.
the protein level of 15-hydroxyprostaglandin dehydrogenase (15-PGDH), a key enzyme in prostaglandin metabolism, in Amyotrophic lateral sclerosis model mice at three different disease stages, was investigated.
15-PGDH is downregulated in human hepatoma cells with a high COX-2 (Montrer COX2 Kits ELISA) expression, in chemical and genetic murine models of hepatocellular carcinoma (HCC (Montrer FAM126A Kits ELISA)) and in human HCC (Montrer FAM126A Kits ELISA) biopsies.
Data from a mouse model suggest that expression of Hpgd protein in uterus is down-regulated in lipopolysaccharide/infection-induced embryo loss.
prostaglandin E synthase (Montrer PTGES Kits ELISA) (cPGES/p23 (Montrer PTGES3 Kits ELISA)) acts as a regulatory factor for expression of a prostaglandin E2 -inactivating enzyme,15-hydroxyprostaglandin dehydrogenase ( 15-PGDH).
I. sinclarii is effective in lowering blood glucose due to the upregulation of glucokinase (Gk (Montrer GCK Kits ELISA)-rs1 (Montrer RS1 Kits ELISA)) and downregulation of hydroxyprostaglandin dehydrogenase.
OAT (Montrer OAT Kits ELISA)-PG is proposed to be involved in the local PGE (Montrer LIPF Kits ELISA)(2) clearance and metabolism for the inactivation of prostaglandin signals in the kidney cortex.
novel tumor suppressive role for 15-PGDH due to loss of expression during colorectal tumor progression
15-Hydroxyprostaglandin dehydrogenase (Montrer CBR1 Kits ELISA) has a role in suppressing colon tumorigenesis
The intrarenal distribution of 15-PGDH and its interactions with COX-2 (Montrer COX2 Kits ELISA) suggest that differential regulation of COX-2 (Montrer COX2 Kits ELISA) and 15-PGDH plays a role in determining levels of prostaglandins involved in regulation of salt, volume, and blood pressure homeostasis.
Data indicate that 15-hydroxyprostaglandin dehydrogenase (15-PGDH) inhibitor TD88 could be a good effector on wound healing, especially in the aspects of prevention of scarring.
The data indicate that decreased expression of 15-hydroxyprostaglandin dehydrogenase in the fetal membranes may contribute to the increase in intrauterine prostaglandin concentrations at term, stimulating the onset of labor.
The reduced 15-PGDH may result in PGE2 accumulation which sustains carcinogenesis and tumor progression. We further found that miR (Montrer MLXIP Kits ELISA)-21 exert its oncogenic role through PGE2/PI3K (Montrer PIK3CA Kits ELISA)/Akt (Montrer AKT1 Kits ELISA)/Wnt (Montrer WNT2 Kits ELISA)/beta-catenin (Montrer CTNNB1 Kits ELISA) axis in gastric cell proliferation. In conclusion, our findings enlarged our knowledge in the roles of miR (Montrer MLXIP Kits ELISA)-21 in the progression of gastric cancer.
WNT5A (Montrer WNT5A Kits ELISA) signaling regulates 15-PGDH expression.
miR (Montrer MLXIP Kits ELISA)-21-HPGD regulatory module may play an important role as part of a feed-forward loop that regulates the PGE2 signaling. Such a feed-forward regulatory mechanism likely plays a critical role in OTSCC initiation and progression.
inhibitory effects of 17-AAG (Montrer MPG Kits ELISA) on PGE2 levels in HT-29 colorectal cancer cells were mediated through modulating COX-2 (Montrer COX2 Kits ELISA) and 15-PGDH expression.
A common mutation and a novel mutation in HPGD gene were identified to be responsible for primary hypertrophic osteoarthropathy
Peroxisome proliferator-activated receptors (PPARs) play pivotal roles in maintenance of Chorionic NAD-dependent 15-hydroxy prostaglandin dehydrogenase (PGDH) expression in chorion during human pregnancy.
Neoadjuvant chemotherapy could increase 15-PGDH expression in advanced gastric cancer patients, and 15-PGDH may serve as a candidate prognostic biomarker of advanced GC response to therapy.
15-PGDH mRNA levels were significantly higher in aorta samples from patients undergoing abdominal aortic aneurysm repair than in those from healthy multiorgan donors.
Omega-3 polyunsaturated fatty acids upregulate the expression of 15-PGDH by inhibiting miR (Montrer MLXIP Kits ELISA)-26a and miR (Montrer MLXIP Kits ELISA)-26b.
Multiple drug resistance-associated protein (Montrer ABCC1 Kits ELISA) 4 (MRP4 (Montrer ABCC4 Kits ELISA)), prostaglandin transporter (PGT (Montrer SLCO2A1 Kits ELISA)), and 15-hydroxyprostaglandin dehydrogenase (15-PGDH) as determinants of PGE2 levels in cancer.
HPGD may play a role during establishment and termination of gestation
This gene encodes a member of the short-chain nonmetalloenzyme alcohol dehydrogenase protein family. The encoded enzyme is responsible for the metabolism of prostaglandins, which function in a variety of physiologic and cellular processes such as inflammation. Mutations in this gene result in primary autosomal recessive hypertrophic osteoarthropathy and cranioosteoarthropathy. Multiple transcript variants encoding different isoforms have been found for this gene.
, hydroxyprostaglandin dehydrogenase 15-(NAD)
, 15-hydroxyprostaglandin dehydrogenase [NAD(+)]
, prostaglandin dehydrogenase 1
, NAD-dependent 15-hydroxyprostaglandin dehydrogenase
, 15-hydroxyprostaglandin dehydrogenase (NAD+)
, NAD+-dependent 15-hydroxyprostaglandin dehydrogenase
, short chain dehydrogenase/reductase family 36C, member 1
, NAD+ dependent 15-hydroxyprostaglandin dehydrogenase